Live Analyst Rating Changes 19732 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Gerhard Orgonas
BER

Gerhard Orgonas

Wall Street Analyst
★☆☆☆☆
#2802
on 13Foresight · ranked by our own returns
48%
Success Rate
+3.4%
Average Return
15 of 31 calls profitable · -12.9% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 48% of Gerhard Orgonas's ratings turned a profit when each position was held for 2 year — averaging +3.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

44 Buy 3 Hold 0 Sell
Gerhard's Stock Coverage 32 ratings · 2026-08-07
Company Date Position Consensus Price Target 2-Yr Return vs S&P 500
DE:ACT
AlzChem Group AG
Jul 31, 2026 BUY Strong Buy
+18.6% avg upside
5 analysts
$201.00
26.59% Upside
· ·
DE:YSN
Secunet Security Networks
Jul 31, 2026 BUY Strong Buy
+36.7% avg upside
2 analysts
$254.00
35.61% Upside
· ·
DE:RDC
Redcare Pharmacy
Jul 30, 2026 BUY Strong Buy
+41.0% avg upside
8 analysts
$94.00
47.61% Upside
· ·
DE:G24
Scout24
Jul 08, 2026 BUY Strong Buy
+25.2% avg upside
22 analysts
$140.00
93.17% Upside
+5.8% ·
DE:TNIE
tonies SE Class A
Jul 06, 2026 BUY Strong Buy
+55.9% avg upside
1 analyst
$19.00
55.90% Upside
-4.0% ·
FR:EXA
Exail Technologies
Jun 25, 2026 BUY Buy
-54.8% avg upside
3 analysts
$145.00
16.08% Upside
+6.9% ·
DE:KRN
Krones AG
Jun 09, 2026 BUY Hold
-12.1% avg upside
17 analysts
$165.00
41.33% Upside
+4.5% ·
DE:EVD
CTS Eventim AG & Co. KGaA
Jun 09, 2026 BUY Strong Buy
+65.5% avg upside
14 analysts
$88.00
51.48% Upside
+22.6% ·
DE:DMP
Dermapharm Holding SE
May 14, 2026 BUY Buy
+14.2% avg upside
2 analysts
$60.00
45.82% Upside
-17.8% ·
DE:HYQ
HYPOPORT
May 12, 2026 BUY Strong Buy
+203.0% avg upside
7 analysts
$190.00
122.31% Upside
+1.5% ·
CH:DOCM
DocMorris
Mar 23, 2026 HOLD Buy
+488.0% avg upside
9 analysts
$4.45
54.06% Downside
+162.3% ·
DE:MBB
MBB SE
Jan 12, 2026 HOLD Buy
-13.6% avg upside
2 analysts
$226.00
19.74% Upside
-8.3% ·
DE:SBS
STRATEC Biomedical
Sep 10, 2025 BUY Buy
+196.6% avg upside
5 analysts
$51.00
152.45% Upside
-25.1% ·
DE:JST
JOST Werke AG
Sep 10, 2025 BUY Strong Buy
+9.7% avg upside
3 analysts
$68.00
19.38% Upside
+21.7% ·
DE:ADN1
adesso AG
Sep 10, 2025 BUY Strong Buy
+161.0% avg upside
8 analysts
$137.00
129.89% Upside
-38.9% ·
DE:NB2
Northern Data AG
Sep 05, 2025 BUY Buy
+184.7% avg upside
2 analysts
$27.00
291.82% Upside
-72.9% ·
FR:MF
Wendel SE
Jul 21, 2025 BUY Strong Buy
+28.1% avg upside
5 analysts
$115.00
32.19% Upside
-3.1% ·
DE:BDT
Bertrandt
Dec 13, 2024 HOLD Sell
+344.7% avg upside
10 analysts
$25.00
188.02% Upside
-53.3% ·
DE:DFV
DFV Deutsche Familienversicherung AG
Jun 03, 2023 BUY Strong Buy
+92.0% avg upside
1 analyst
$14.40
92.05% Upside
· ·
DE:GLJ
GRENKE AG
Mar 21, 2023 BUY Hold
+287.9% avg upside
10 analysts
$40.00
236.20% Upside
-38.6% ·
DE:AR4
AURELIUS Equity Opportunities SE & Co. KGaA
Aug 16, 2022 BUY Strong Buy
-90.1% avg upside
2 analysts
$45.00
92.10% Downside
· ·
DE:AAG
Aumann AG
May 23, 2022 HOLD Hold
+75.4% avg upside
2 analysts
$18.00
31.82% Upside
+19.0% ·
DE:SHF
SNP Schneider Neureither & Partner AG (Schneider Neureither & Partner AG)
Aug 11, 2021 HOLD Hold
-17.1% avg upside
2 analysts
$65.00
20.22% Downside
-37.8% ·
DE:BFSA
Befesa S.A.
Jul 14, 2021 BUY Strong Buy
+40.1% avg upside
7 analysts
$78.00
116.01% Upside
-45.0% ·
DE:AOF
ATOSS Software
Jul 14, 2021 BUY Strong Buy
+67.6% avg upside
4 analysts
$220.00
153.76% Upside
+14.7% ·
DE:BSL
Basler AG
Jul 16, 2020 BUY Strong Buy
+62.9% avg upside
4 analysts
$74.00
217.00% Upside
+59.4% ·
DE:ED4
EDAG Engineering
Nov 20, 2019 HOLD Buy
+298.4% avg upside
4 analysts
$12.00
272.76% Upside
+12.9% ·
DE:TTK
TAKKT AG
Nov 29, 2018 BUY Strong Buy
+598.8% avg upside
8 analysts
$22.50
886.82% Upside
-18.8% ·
DE:NFN
NFON AG
Nov 29, 2018 BUY Hold
+302.0% avg upside
2 analysts
$22.00
516.17% Upside
+64.4% ·
DE:TPE
PVA TePla
Nov 29, 2018 BUY Strong Buy
+8.6% avg upside
6 analysts
$15.00
51.00% Downside
+17.9% ·
DE:FTK
flatexDEGIRO AG
Sep 27, 2018 BUY Strong Buy
+22.7% avg upside
9 analysts
$43.00
22.20% Upside
+45.8% ·
DE:HOC
HolidayCheck
Sep 27, 2018 BUY Strong Buy
+11.5% avg upside
1 analyst
$4.80
11.54% Upside
· ·
🔒 27 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Gerhard Orgonas — Frequently Asked Questions
How accurate are Gerhard Orgonas's stock ratings?
Based on the calls 13Foresight could measure, about 32% of Gerhard's ratings were profitable over a one-year hold, with an average return of +0.2% per rating, or -9.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Gerhard ranked on 13Foresight?
Gerhard Orgonas is currently ranked #2802 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Gerhard cover?
Gerhard most recently has ratings on DE:ACT, DE:YSN, DE:RDC, DE:G24, DE:TNIE, FR:EXA, DE:KRN, DE:EVD, DE:DMP, DE:HYQ, CH:DOCM, DE:MBB and 20 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.